Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2012


2nd Annual World Orphan Drug Congress 2012

17 Oct 2012 - 18 Oct 2012 - Barcelona, Spain



Bookmark and Share


In order to discuss major concerns, the newest solutions and challenges connected with prevention, diagnosis and treatment of rare diseases, Fleming Europe has organized its 2nd Annual Orphan Drug Congress 2012. On 17 – 18 October 2012 the top-level pharmaceutical experts in orphan drug development, regulatory affairs & pricing will gather in Barcelona to discuss this year's critical issues.

Focused interactive discussions integrated between individual presentation blocks will provide enough space and a unique opportunity to exchange ideas with industry peers and get the answers from our speakers.

The attendees will have the opportunity to:

  • Understand the infrastructure in order to gain approval in emerging markets 
  • Gain critical insights behind the successful development, authorization and  reimbursement of rare disease drugs 
  • Find out how to regulate the use of social media for orphan drugs & rare diseases 
  • Explore the importance of communication Between Pharma, Patient & HTA Bodies 
  • Meet the top executives and experts from leading pharmaceutical companies as well as  from medium and small pharma companies with the focus on rare and neglected    diseases

For further details please request the event brochure http://pharma.flemingeurope.com/orphan-drug-congress/request-agenda




Further information
Scientific News
Big Genetics in BC: The American Society for Human Genetics 2016 Meeting
Themes at this year's meeting ranged from the verification, validation, and sharing of data, to the translation of laboratory findings into actionable clinical results.
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Automated Low Volume Dispensing Trends
Gain a better understanding of the current and future market requirements for fully automated LVD systems.
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
Unique Visual Stimulation May Be New Treatment for Alzheimer’s
Noninvasive technique reduces beta amyloid plaques in mouse models of Alzheimer’s disease.
Major Neuroscience Initiative Launched
Tianqiao and Chrissy Chen Institute invest $115 million to further expand neuroscience research, while Caltech construct $200 million biosciences complex.
Making It Personal
Cancer vaccine linked to increased immune response against leukemia cells.
Genetics Control Regenerative Properties Of Stem Cells
Researchers define how genetic factors control regenerative properties of blood-forming stem cells.
Diabetes Missing Link Discovered
Researchers from the University of Auckland have shown that beta catenin plays a vital role in the control of insulin release from the pancreas.
Study Reveals New Role for Hippo Pathway in Suppressing Cancer Immunity
Hippo pathway signaling regulates organ size by moderating cell growth, apoptosis and stem cell renewal, but dysregulation contributes to cancer development.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!